{"id":52999,"date":"2025-12-19T19:46:21","date_gmt":"2025-12-19T10:46:21","guid":{"rendered":"https:\/\/www.marketresearch.jp\/reports\/?p=52999"},"modified":"2026-09-25T14:03:28","modified_gmt":"2026-09-25T05:03:28","slug":"pharmaceutical-grade-adapalene-market","status":"publish","type":"post","link":"https:\/\/www.marketresearch.jp\/reports\/pharmaceutical-grade-adapalene-market\/","title":{"rendered":"\u4e16\u754c\u306e\u533b\u85ac\u54c1\u30b0\u30ec\u30fc\u30c9\u30a2\u30c0\u30d1\u30ec\u30f3\u5e02\u5834\uff1a\u51e6\u65b9\u533a\u5206\u5225\uff08OTC\u3001\u51e6\u65b9\u7b8b\u533b\u85ac\u54c1\uff09\u3001\u5264\u5f62\u5225\uff08\u30af\u30ea\u30fc\u30e0\u3001\u30b2\u30eb\u3001\u30ed\u30fc\u30b7\u30e7\u30f3\uff09\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225 &#8211; \u30b0\u30ed\u30fc\u30d0\u30eb\u4e88\u6e2c 2025-2032\u5e74"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.jp\/reports\/wp-content\/uploads\/2025\/12\/pharmaceutical-grade-adapalene-statistics.png\" alt=\"Market Statistics\" style=\"max-width:100%;\"><\/p>\n<p>\u4ee5\u4e0b\u306b\u3001\u3054\u63d0\u4f9b\u3044\u305f\u3060\u3044\u305f\u300cBasic TOC\u300d\u3068\u300cSegmentation Details\u300d\u306b\u57fa\u3065\u304d\u3001\u8a73\u7d30\u306a\u76ee\u6b21\u3092\u65e5\u672c\u8a9e\u3067\u69cb\u7bc9\u3057\u307e\u3059\u3002<\/p>\n<p>&#8212;<\/p>\n<p>**\u76ee\u6b21**<\/p>\n<p>1.  **\u5e8f\u6587** (Preface)<br \/>\n2.  **\u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3068\u5bfe\u8c61\u7bc4\u56f2** (Market Segmentation &#038; Coverage)<br \/>\n3.  **\u8abf\u67fb\u5bfe\u8c61\u671f\u9593** (Years Considered for the Study)<br \/>\n4.  **\u901a\u8ca8** (Currency)<br \/>\n5.  **\u8a00\u8a9e** (Language)<br \/>\n6.  **\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc** (Stakeholders)<br \/>\n7.  **\u8abf\u67fb\u65b9\u6cd5** (Research Methodology)<br \/>\n8.  **\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc** (Executive Summary)<br \/>\n9.  **\u5e02\u5834\u6982\u8981** (Market Overview)<br \/>\n10. **\u5e02\u5834\u30a4\u30f3\u30b5\u30a4\u30c8** (Market Insights)<br \/>\n    *   \u5f8c\u767a\u533b\u85ac\u54c1\u30b0\u30ec\u30fc\u30c9\u30a2\u30c0\u30d1\u30ec\u30f3\u5e02\u5834\u53c2\u5165\u6226\u7565\u306b\u5bfe\u3059\u308b\u7279\u8a31\u5207\u308c\u9593\u8fd1\u306e\u5f71\u97ff (Impact of impending patent expirations on generic pharmaceutical grade adapalene market entry strategies)<br \/>\n    *   \u30a2\u30c0\u30d1\u30ec\u30f3\u5916\u7528\u88fd\u5264\u306e\u5b89\u5b9a\u6027\u5411\u4e0a\u3068\u5f90\u653e\u6027\u5236\u5fa1\u306e\u305f\u3081\u306e\u30de\u30a4\u30af\u30ed\u30ab\u30d7\u30bb\u30eb\u5316\u6280\u8853\u306e\u7d71\u5408 (Integration of microencapsulation technology to improve stability and controlled release of adapalene topical formulations)<br \/>\n    *   \u9060\u9694\u60a3\u8005\u306b\u304a\u3051\u308b\u533b\u85ac\u54c1\u30b0\u30ec\u30fc\u30c9\u30a2\u30c0\u30d1\u30ec\u30f3\u30b2\u30eb\u306e\u63a1\u7528\u3092\u4fc3\u9032\u3059\u308b\u9060\u9694\u76ae\u819a\u79d1\u51e6\u65b9\u306e\u6025\u5897 (Surge in teledermatology prescriptions driving uptake of \u533b\u85ac\u54c1\u30b0\u30ec\u30fc\u30c9\u30a2\u30c0\u30d1\u30ec\u30f3 gel among remote patients)<br \/>\n    *   \u30a2\u30c0\u30d1\u30ec\u30f3\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u62e1\u5927\u306e\u305f\u3081\u306e\u5f8c\u767a\u533b\u85ac\u54c1\u30e1\u30fc\u30ab\u30fc\u3068\u76ae\u819a\u79d1\u30b5\u30fc\u30d3\u30b9\u30d7\u30ed\u30d0\u30a4\u30c0\u30fc\u9593\u306e\u6226\u7565\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7 (Strategic partnerships between generic manufacturers and dermatology service providers to expand adapalene distribution channels)<br \/>\n    *   \u4e2d\u7b49\u5ea6\u304b\u3089\u91cd\u5ea6\u306e\u30cb\u30ad\u30d3\u3092\u5bfe\u8c61\u3068\u3057\u305f\u65b0\u898f\u9ad8\u6fc3\u5ea6\u30a2\u30c0\u30d1\u30ec\u30f3\u88fd\u5264\u306e\u4e16\u754c\u7684\u306a\u85ac\u4e8b\u627f\u8a8d (Regulatory approvals for novel high-concentration adapalene formulations targeting moderate to severe acne globally)<br \/>\n    *   \u5916\u7528\u7642\u6cd5\u306b\u304a\u3051\u308b\u30a2\u30c0\u30d1\u30ec\u30f3\u306e\u7d4c\u76ae\u6d78\u900f\u3092\u9ad8\u3081\u308b\u305f\u3081\u306e\u30ca\u30ce\u30a8\u30de\u30eb\u30b7\u30e7\u30f3\u306a\u3069\u306e\u30d3\u30d2\u30af\u30eb\u30d9\u30fc\u30b9\u306e\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306e\u63a1\u7528\u5897\u52a0 (Rising adoption of vehicle-based innovations such as nanoemulsions to enhance dermal penetration of adapalene in topical therapies)<br \/>\n11. **2025\u5e74\u7c73\u56fd\u95a2\u7a0e\u306e\u7d2f\u7a4d\u7684\u5f71\u97ff** (Cumulative Impact of United States Tariffs 2025)<br \/>\n12. **2025\u5e74\u4eba\u5de5\u77e5\u80fd\u306e\u7d2f\u7a4d\u7684\u5f71\u97ff** (Cumulative Impact of Artificial Intelligence 2025)<br \/>\n13. **\u533b\u85ac\u54c1\u30b0\u30ec\u30fc\u30c9\u30a2\u30c0\u30d1\u30ec\u30f3\u5e02\u5834\u3001\u51e6\u65b9\u72b6\u6cc1\u5225** (Pharmaceutical Grade Adapalene Market, by Prescription Status)<br \/>\n    *   \u5e02\u8ca9\u85ac (OTC) (Over The Counter)<br \/>\n        *   0.1%\u6fc3\u5ea6 (0.1% Strength)<br \/>\n    *   \u51e6\u65b9\u85ac (Prescription)<br \/>\n        *   0.1%\u6fc3\u5ea6 (0.1% Strength)<br \/>\n        *   0.3%\u6fc3\u5ea6 (0.3% Strength)<br \/>\n14. **\u533b\u85ac\u54c1\u30b0\u30ec\u30fc\u30c9\u30a2\u30c0\u30d1\u30ec\u30f3\u5e02\u5834\u3001\u88fd\u5264\u5225** (Pharmaceutical Grade Adapalene Market, by Formulation)<br \/>\n    *   \u30af\u30ea\u30fc\u30e0 (Cream)<br \/>\n    *   \u30b2\u30eb (Gel)<br \/>\n    *   \u30ed\u30fc\u30b7\u30e7\u30f3 (Lotion)<br \/>\n    *   \u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3 (Solution)<br \/>\n15. **\u533b\u85ac\u54c1\u30b0\u30ec\u30fc\u30c9\u30a2\u30c0\u30d1\u30ec\u30f3\u5e02\u5834\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225** (Pharmaceutical Grade Adapalene Market, by Distribution Channel)<br \/>\n    *   \u75c5\u9662\u85ac\u5c40 (Hospital Pharmacy)<br \/>\n    *   \u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40 (Online Pharmacy)<br \/>\n    *   \u5c0f\u58f2\u85ac\u5c40 (Retail Pharmacy)<br \/>\n16. **\u533b\u85ac\u54c1\u30b0\u30ec\u30fc\u30c9\u30a2\u30c0\u30d1\u30ec\u30f3\u5e02\u5834\u3001\u5730\u57df\u5225** (Pharmaceutical Grade Adapalene Market, by Region)<br \/>\n    *   \u7c73\u5dde (Americas)<br \/>\n        *   \u5317\u7c73 (North America)<br \/>\n        *   \u4e2d\u5357\u7c73 (Latin America)<br \/>\n    *   \u6b27\u5dde\u3001\u4e2d\u6771\u3001\u30a2\u30d5\u30ea\u30ab (Europe, Middle East &#038; Africa)<br \/>\n        *   \u6b27\u5dde (Europe)<br \/>\n        *   \u4e2d\u6771 (Middle East)<br \/>\n        *   \u30a2\u30d5\u30ea\u30ab (Africa)<br \/>\n    *   \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b (Asia-Pacific)<br \/>\n17. **\u533b\u85ac\u54c1\u30b0\u30ec\u30fc\u30c9\u30a2\u30c0\u30d1\u30ec\u30f3\u5e02\u5834\u3001\u30b0\u30eb\u30fc\u30d7\u5225** (Pharmaceutical Grade Adapalene Market, by Group)<br \/>\n    *   ASEAN<br \/>\n    *   GCC<br \/>\n    *   \u6b27\u5dde\u9023\u5408 (European Union)<br \/>\n    *   BRICS<br \/>\n    *   G7<br \/>\n    *   NATO<br \/>\n18. **\u533b\u85ac\u54c1\u30b0\u30ec\u30fc\u30c9\u30a2\u30c0\u30d1\u30ec\u30f3\u5e02\u5834\u3001\u56fd\u5225** (Pharmaceutical Grade Adapalene Market, by Country)<br \/>\n    *   \u7c73\u56fd (United States)<br \/>\n    *   \u30ab\u30ca\u30c0 (Canada)<br \/>\n    *   \u30e1\u30ad\u30b7\u30b3 (Mexico)<br \/>\n    *   \u30d6\u30e9\u30b8\u30eb (Brazil)<br \/>\n    *   \u82f1\u56fd (United Kingdom)<br \/>\n    *   \u30c9\u30a4\u30c4 (Germany)<br \/>\n    *   \u30d5\u30e9\u30f3\u30b9 (France)<br \/>\n    *   \u30ed\u30b7\u30a2 (Russia)<br \/>\n    *   \u30a4\u30bf\u30ea\u30a2 (Italy)<br \/>\n    *   \u30b9\u30da\u30a4\u30f3 (Spain)<br \/>\n    *   \u4e2d\u56fd (China)<br \/>\n    *   \u30a4\u30f3\u30c9 (India)<br \/>\n    *   \u65e5\u672c (Japan)<br \/>\n    *   \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2 (Australia)<br \/>\n    *   \u97d3\u56fd (South Korea)<br \/>\n19. **\u7af6\u4e89\u74b0\u5883** (Competitive Landscape)<br \/>\n    *   \u5e02\u5834\u30b7\u30a7\u30a2\u5206\u6790\u30012024\u5e74 (Market Share Analysis, 2024)<br \/>\n    *   FPNV\u30dd\u30b8\u30b7\u30e7\u30cb\u30f3\u30b0\u30de\u30c8\u30ea\u30c3\u30af\u30b9\u30012024\u5e74 (FPNV Positioning Matrix, 2024)<br \/>\n    *   \u7af6\u5408\u5206\u6790 (Competitive Analysis)<br \/>\n        *   \u30ac\u30eb\u30c7\u30eb\u30deS.A. (Galderma S.A.)<br \/>\n        *   \u30b5\u30f3\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30fb\u30a4\u30f3\u30c0\u30b9\u30c8\u30ea\u30fc\u30ba\u30fb\u30ea\u30df\u30c6\u30c3\u30c9 (Sun Pharmaceutical Industries Ltd.)<br \/>\n        *   \u30c9\u30af\u30bf\u30fc\u30fb\u30ec\u30c7\u30a3\u30fc\u30ba\u30fb\u30e9\u30dc\u30e9\u30c8\u30ea\u30fc\u30ba\u30fb\u30ea\u30df\u30c6\u30c3\u30c9 (Dr. Reddy&#8217;s Laboratories Ltd.)<br \/>\n        *   \u30f4\u30a3\u30a2\u30c8\u30ea\u30b9\u30fb\u30a4\u30f3\u30af (Viatris Inc.)<br \/>\n        *   \u30c6\u30d0\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30fb\u30a4\u30f3\u30c0\u30b9\u30c8\u30ea\u30fc\u30ba\u30fb\u30ea\u30df\u30c6\u30c3\u30c9 (Teva Pharmaceutical Industries Ltd.)<br \/>\n        *   \u30b0\u30ec\u30f3\u30de\u30fc\u30af\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u30fb\u30ea\u30df\u30c6\u30c3\u30c9 (Glenmark Pharmaceuticals Limited)<br \/>\n        *   \u30eb\u30d4\u30f3\u30fb\u30ea\u30df\u30c6\u30c3\u30c9 (Lupin Limited)<br \/>\n        *   \u30b7\u30d7\u30e9\u30fb\u30ea\u30df\u30c6\u30c3\u30c9 (Cipla Limited)<br \/>\n        *   \u30bf\u30ed\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30fb\u30a4\u30f3\u30c0\u30b9\u30c8\u30ea\u30fc\u30ba\u30fb\u30ea\u30df\u30c6\u30c3\u30c9 (Taro Pharmaceutical Industries Ltd.)<br \/>\n        *   \u30b5\u30f3\u30c9\u30fb\u30a4\u30f3\u30bf\u30fc\u30ca\u30b7\u30e7\u30ca\u30ebGmbH (Sandoz International GmbH)<br \/>\n20. **\u56f3\u76ee\u6b21** [\u5408\u8a08: 26] (List of Figures [Total: 26])<br \/>\n21. **\u8868\u76ee\u6b21** [\u5408\u8a08: 411] (List of Tables [Total: 411 ])<\/p>\n<p>&#8230;&#8230;&#8230;&#8230; (\u4ee5\u4e0b\u7701\u7565)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u533b\u85ac\u54c1\u30b0\u30ec\u30fc\u30c9\u30a2\u30c0\u30d1\u30ec\u30f3\u5e02\u5834\u306f\u3001\u5c40\u6240\u30ec\u30c1\u30ce\u30a4\u30c9\u7642\u6cd5\u3001\u7279\u306b\u30cb\u30ad\u30d3\u6cbb\u7642\u306b\u304a\u3051\u308b\u9769\u65b0\u304c\u6ce8\u76ee\u3055\u308c\u308b\u5206\u91ce\u3067\u3042\u308a\u3001\u898f\u5236\u5f53\u5c40\u3001\u81e8\u5e8a\u533b\u3001\u5546\u696d\u95a2\u4fc2\u8005\u304c\u305d\u306e\u52d5\u5411\u306b\u6df1\u304f\u95a2\u4e0e\u3057\u3066\u3044\u307e\u3059\u3002\u672c\u5e02\u5834\u306f\u3001\u30a2\u30c0\u30d1\u30ec\u30f3\u88fd\u5264\u306e\u91cd\u8981\u306a\u7279\u6027\u3001\u30cb\u30ad\u30d3\u7ba1\u7406\u306b\u304a\u3051\u308b\u81e8\u5e8a\u7684\u6709\u7528\u6027\u3001\u304a\u3088\u3073\u305d\u306e\u5165\u624b\u53ef\u80fd\u6027\u3068\u63a1\u7528\u3092\u5f62\u6210\u3059\u308b\u898f\u5236\u4e0a\u304a\u3088\u3073\u5546\u696d\u4e0a\u306e\u529b\u304c\u4ea4\u932f\u3059\u308b\u8907\u96d1\u306a\u72b6\u6cc1\u3092\u5448\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u5305\u62ec\u7684\u306a\u5e02\u5834\u5206\u6790\u306f\u3001\u30a2\u30c0\u30d1\u30ec\u30f3\u306e\u85ac\u7406\u5b66\u7684\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3001\u81e8\u5e8a\u8a3a\u7642\u3067\u4e00\u822c\u7684\u306b\u4f7f\u7528\u3055\u308c\u308b\u5f37\u5ea6\u3001\u304a\u3088\u3073\u30d6\u30e9\u30f3\u30c9\u54c1\u3068\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u54c1\u306e\u533a\u5225\u3092\u660e\u78ba\u306b\u3059\u308b\u3053\u3068\u3067\u3001\u6226\u7565\u7684\u610f\u601d\u6c7a\u5b9a\u3092\u5f62\u6210\u3059\u308b\u6cbb\u7642\u7279\u6027\u3068\u5546\u696d\u7684\u30fb\u898f\u5236\u7684\u8981\u56e0\u3092\u6574\u5408\u3055\u305b\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u30a2\u30c0\u30d1\u30ec\u30f3\u306f\u76ae\u819a\u79d1\u5b66\u306b\u304a\u3044\u3066\u78ba\u7acb\u3055\u308c\u305f\u5f79\u5272\u3092\u62c5\u3063\u3066\u3044\u307e\u3059\u304c\u3001\u88fd\u54c1\u51e6\u65b9\u3001\u60a3\u8005\u306e\u597d\u307f\u3001\u6d41\u901a\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u6700\u8fd1\u306e\u9032\u5c55\u306b\u3088\u3063\u3066\u3001\u305d\u306e\u5e02\u5834\u74b0\u5883\u306f\u5e38\u306b\u9032\u5316\u3057\u3066\u3044\u307e\u3059\u3002\u672c\u5831\u544a\u66f8\u306f\u3001\u9ad8\u30ec\u30d9\u30eb\u306e\u5e02\u5834\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u304b\u3089\u3001\u8a73\u7d30\u306a\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306e\u6d1e\u5bdf\u3001\u5730\u57df\u3054\u3068\u306e\u30cb\u30e5\u30a2\u30f3\u30b9\u306b\u81f3\u308b\u307e\u3067\u3001\u69cb\u9020\u5316\u3055\u308c\u305f\u8003\u5bdf\u3092\u63d0\u4f9b\u3057\u3001\u696d\u754c\u30ea\u30fc\u30c0\u30fc\u304c\u88fd\u54c1\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u3068\u5e02\u5834\u6295\u5165\u6226\u7565\u3092\u6700\u9069\u5316\u3059\u308b\u305f\u3081\u306e\u5b9f\u7528\u7684\u306a\u30ac\u30a4\u30c0\u30f3\u30b9\u3092\u63d0\u793a\u3057\u307e\u3059\u3002<\/p>\n<p>\u533b\u85ac\u54c1\u30b0\u30ec\u30fc\u30c9\u30a2\u30c0\u30d1\u30ec\u30f3\u5e02\u5834\u306f\u3001\u6cbb\u7642\u3001\u898f\u5236\u3001\u5546\u696d\u306e\u5404\u8ef8\u304c\u4ea4\u5dee\u3059\u308b\u591a\u89d2\u7684\u306a\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u30a2\u30d7\u30ed\u30fc\u30c1\u306b\u3088\u3063\u3066\u3001\u88fd\u54c1\u6226\u7565\u3068\u5e02\u5834\u884c\u52d5\u3092\u8a73\u7d30\u306b\u5b9a\u7fa9\u3057\u3066\u3044\u307e\u3059\u3002\u30bf\u30a4\u30d7\u5225\u3067\u306f\u3001\u30d6\u30e9\u30f3\u30c9\u54c1\u3068\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u54c1\u306b\u5927\u5225\u3055\u308c\u3001\u305d\u308c\u305e\u308c\u304c0.1%\u30680.3%\u306e\u5f37\u5ea6\u3067\u3055\u3089\u306b\u7d30\u5206\u5316\u3055\u308c\u3001\u30dd\u30b8\u30b7\u30e7\u30cb\u30f3\u30b0\u3001\u4fa1\u683c\u8a2d\u5b9a\u306e\u6839\u62e0\u3001\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3\u6226\u7565\u3092\u5f62\u6210\u3057\u307e\u3059\u3002\u51e6\u65b9\u72b6\u6cc1\u3067\u306f\u3001\u5e02\u8ca9\u85ac\uff08OTC\uff09\u3068\u51e6\u65b9\u85ac\u306b\u5206\u304b\u308c\u307e\u3059\u3002\u7279\u5b9a\u306e\u5f37\u5ea6\u3067\u306eOTC\u306e\u5165\u624b\u53ef\u80fd\u6027\u306f\u3001\u5e97\u982d\u3067\u306e\u63a8\u5968\u3084\u30de\u30b9\u30de\u30fc\u30b1\u30c3\u30c8\u5411\u3051\u30e1\u30c3\u30bb\u30fc\u30b8\u30f3\u30b0\u3092\u5909\u5316\u3055\u305b\u308b\u4e00\u65b9\u3001\u51e6\u65b9\u85ac\u30c1\u30e3\u30cd\u30eb\u306f\u9ad8\u5f37\u5ea6\u88fd\u5264\u306b\u5bfe\u3059\u308b\u81e8\u5e8a\u7684\u76e3\u7763\u3092\u7dad\u6301\u3057\u307e\u3059\u3002\u88fd\u5264\u30bf\u30a4\u30d7\u306f\u3001\u30af\u30ea\u30fc\u30e0\u3001\u30b8\u30a7\u30eb\u3001\u30ed\u30fc\u30b7\u30e7\u30f3\u3001\u6eb6\u6db2\u3068\u3044\u3063\u305f\u88fd\u5264\u306e\u9078\u629e\u306f\u3001\u60a3\u8005\u306e\u5fcd\u5bb9\u6027\u3068\u69d8\u3005\u306a\u808c\u30bf\u30a4\u30d7\u3078\u306e\u9069\u5408\u6027\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u3001\u30c1\u30e3\u30cd\u30eb\u63a8\u5968\u3068\u30d7\u30ed\u30e2\u30fc\u30b7\u30e7\u30f3\u6226\u8853\u3092\u6c7a\u5b9a\u3057\u307e\u3059\u3002\u5f37\u5ea6\u306b\u95a2\u3057\u3066\u306f\u30010.1%\u30680.3%\u306e\u30d5\u30a9\u30fc\u30de\u30c3\u30c8\u306f\u3001\u52b9\u679c\u306e\u767a\u73fe\u3068\u5fcd\u5bb9\u6027\u306b\u95a2\u3057\u3066\u7570\u306a\u308b\u671f\u5f85\u3092\u751f\u307f\u51fa\u3057\u3001\u81e8\u5e8a\u533b\u304c\u6cbb\u7642\u3092\u8abf\u6574\u3059\u308b\u969b\u306e\u4e2d\u5fc3\u7684\u306a\u81e8\u5e8a\u7684\u30ec\u30d0\u30fc\u3068\u306a\u308a\u307e\u3059\u3002\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u306f\u3001\u75c5\u9662\u85ac\u5c40\u3001\u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40\u3001\u5c0f\u58f2\u85ac\u5c40\u306b\u533a\u5206\u3055\u308c\u3001\u305d\u308c\u305e\u308c\u304c\u7570\u306a\u308b\u904b\u7528\u4e0a\u304a\u3088\u3073\u5546\u696d\u4e0a\u306e\u7279\u6027\u3092\u6301\u3061\u307e\u3059\u3002\u75c5\u9662\u85ac\u5c40\u306f\u51e6\u65b9\u96c6\u30d7\u30ed\u30bb\u30b9\u3068\u6a5f\u95a2\u8abf\u9054\u306b\u3001\u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40\u306f\u5229\u4fbf\u6027\u3068\u30ea\u30d4\u30fc\u30c8\u8cfc\u5165\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u306b\u3001\u5c0f\u58f2\u85ac\u5c40\u306f\u30a2\u30af\u30bb\u30b9\u3057\u3084\u3059\u3055\u3068\u5e97\u982d\u3067\u306e\u30ab\u30a6\u30f3\u30bb\u30ea\u30f3\u30b0\u306b\u91cd\u70b9\u3092\u7f6e\u3044\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306f\u3001\u30bf\u30fc\u30b2\u30c3\u30c8\u3092\u7d5e\u3063\u305f\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u7ba1\u7406\u3001\u30c1\u30e3\u30cd\u30eb\u56fa\u6709\u306e\u5546\u696d\u5316\u3001\u304a\u3088\u3073\u88fd\u5264\u9769\u65b0\u306e\u7d4c\u8def\u3092\u652f\u63f4\u3059\u308b\u591a\u6b21\u5143\u7684\u306a\u30d5\u30ec\u30fc\u30e0\u30ef\u30fc\u30af\u3092\u69cb\u7bc9\u3057\u3001\u6226\u7565\u7684\u610f\u601d\u6c7a\u5b9a\u3092\u30b5\u30dd\u30fc\u30c8\u3059\u308b\u8a73\u7d30\u306a\u5206\u6790\u3068\u6b63\u78ba\u306a\u53ce\u76ca\u4e88\u6e2c\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/p>\n<p>\u533b\u85ac\u54c1\u30b0\u30ec\u30fc\u30c9\u30a2\u30c0\u30d1\u30ec\u30f3\u306e\u5e02\u5834\u306f\u3001\u88fd\u5264\u79d1\u5b66\u306e\u9032\u6b69\u3001\u652f\u6255\u8005\u306e\u671f\u5f85\u306e\u5909\u5316\u3001\u30c7\u30b8\u30bf\u30eb\u30d8\u30eb\u30b9\u5bfe\u5fdc\u306e\u60a3\u8005\u30b8\u30e3\u30fc\u30cb\u30fc\u306b\u3088\u3063\u3066\u63a8\u9032\u3055\u308c\u308b\u3001\u6280\u8853\u7684\u3001\u898f\u5236\u7684\u3001\u304a\u3088\u3073\u30c1\u30e3\u30cd\u30eb\u4e3b\u5c0e\u306e\u5909\u9769\u7684\u306a\u5909\u5316\u306b\u3088\u3063\u3066\u518d\u5b9a\u7fa9\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u6280\u8853\u9769\u65b0\u3068\u88fd\u5264\u79d1\u5b66\u306e\u9032\u6b69\u3068\u3057\u3066\u3001\u9001\u9054\u5a92\u4f53\u3068\u8ce6\u5f62\u5264\u9069\u5408\u6027\u306e\u9769\u65b0\u306f\u3001\u88fd\u5264\u306e\u9078\u629e\u80a2\u3092\u62e1\u5927\u3057\u3001\u30e1\u30fc\u30ab\u30fc\u306b\u88fd\u54c1\u5dee\u5225\u5316\u6226\u7565\u306e\u898b\u76f4\u3057\u3068\u3001\u5fcd\u5bb9\u6027\u5411\u4e0a\u3092\u8b33\u3046\u4e3b\u5f35\u3078\u306e\u6295\u8cc7\u3092\u4fc3\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u60a3\u8005\u306e\u808c\u30bf\u30a4\u30d7\u3084\u597d\u307f\u306b\u5408\u308f\u305b\u305f\u591a\u69d8\u306a\u88fd\u54c1\u304c\u5e02\u5834\u306b\u6295\u5165\u3055\u308c\u3001\u7af6\u4e89\u512a\u4f4d\u6027\u3092\u78ba\u7acb\u3059\u308b\u6a5f\u4f1a\u304c\u751f\u307e\u308c\u3066\u3044\u307e\u3059\u3002\u898f\u5236\u74b0\u5883\u306e\u9032\u5316\u3067\u306f\u3001\u88fd\u9020\u54c1\u8cea\u3068\u8868\u793a\u306e\u900f\u660e\u6027\u306b\u95a2\u3059\u308b\u898f\u5236\u67a0\u7d44\u307f\u306f\u53b3\u683c\u5316\u3057\u3066\u304a\u308a\u3001\u65b0\u305f\u306a\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u8ca0\u62c5\u3092\u751f\u3080\u4e00\u65b9\u3067\u3001\u5b9f\u8a3c\u3055\u308c\u305f\u88fd\u9020\u53b3\u683c\u6027\u306b\u57fa\u3065\u304f\u30d7\u30ec\u30df\u30a2\u30e0\u306a\u30dd\u30b8\u30b7\u30e7\u30cb\u30f3\u30b0\u306e\u6a5f\u4f1a\u3082\u5275\u51fa\u3057\u3066\u3044\u307e\u3059\u3002\u4e16\u754c\u7684\u306b\u7570\u8cea\u306a\u898f\u5236\u74b0\u5883\u306f\u3001\u5404\u5730\u57df\u306b\u5408\u308f\u305b\u305f\u7533\u8acb\u6226\u7565\u3068\u5730\u57df\u56fa\u6709\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u8a08\u753b\u3092\u5fc5\u8981\u3068\u3057\u3001\u4f01\u696d\u306f\u8907\u96d1\u306a\u898f\u5236\u8981\u4ef6\u306b\u5bfe\u5fdc\u3059\u308b\u305f\u3081\u306e\u67d4\u8edf\u306a\u30a2\u30d7\u30ed\u30fc\u30c1\u304c\u6c42\u3081\u3089\u308c\u307e\u3059\u3002\u51e6\u65b9\u884c\u52d5\u3068\u652f\u6255\u8005\u306e\u671f\u5f85\u306e\u5909\u5316\u3068\u3057\u3066\u3001\u51e6\u65b9\u533b\u306e\u884c\u52d5\u306f\u3001\u30a8\u30d3\u30c7\u30f3\u30b9\u306b\u57fa\u3065\u3044\u305f\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3068\u6bd4\u8f03\u6709\u52b9\u6027\u306e\u8003\u616e\u4e8b\u9805\u3078\u306e\u91cd\u70b9\u304c\u9ad8\u307e\u308b\u306b\u3064\u308c\u3066\u9032\u5316\u3057\u3066\u304a\u308a\u3001\u30d6\u30e9\u30f3\u30c9\u54c1\u3068\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u54c1\u9593\u306e\u7af6\u4e89\u529b\u5b66\u3092\u518d\u8abf\u6574\u3057\u3066\u3044\u307e\u3059\u3002\u652f\u6255\u8005\u304b\u3089\u306e\u8cbb\u7528\u5bfe\u52b9\u679c\u3078\u306e\u5727\u529b\u3082\u3001\u88fd\u54c1\u306e\u63a1\u7528\u3068\u511f\u9084\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u3066\u3044\u307e\u3059\u3002\u30aa\u30e0\u30cb\u30c1\u30e3\u30cd\u30eb\u6d41\u901a\u306e\u53f0\u982d\u3067\u306f\u3001\u5c0f\u58f2\u304a\u3088\u3073\u6d41\u901a\u74b0\u5883\u306f\u3001\u30aa\u30e0\u30cb\u30c1\u30e3\u30cd\u30eb\u306e\u671f\u5f85\u306b\u9069\u5fdc\u3057\u3066\u304a\u308a\u3001\u30aa\u30f3\u30e9\u30a4\u30f3\u304a\u3088\u3073\u85ac\u5c40\u4e3b\u5c0e\u306e\u30a2\u30af\u30bb\u30b9\u304c\u60a3\u8005\u306e\u30a2\u30c9\u30d2\u30a2\u30e9\u30f3\u30b9\u3068\u5229\u4fbf\u6027\u306e\u8a8d\u8b58\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u3066\u3044\u307e\u3059\u3002\u30c7\u30b8\u30bf\u30eb\u30d8\u30eb\u30b9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u666e\u53ca\u306f\u3001\u60a3\u8005\u304c\u88fd\u54c1\u60c5\u5831\u306b\u30a2\u30af\u30bb\u30b9\u3057\u3001\u8cfc\u5165\u3059\u308b\u7d4c\u8def\u3092\u591a\u69d8\u5316\u3055\u305b\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>2025\u5e74\u7c73\u56fd\u95a2\u7a0e\u8abf\u6574\u306e\u5f71\u97ff\u3082\u7121\u8996\u3067\u304d\u307e\u305b\u3093\u30022025\u5e74\u306e\u7c73\u56fd\u95a2\u7a0e\u653f\u7b56\u306e\u5909\u66f4\u306f\u3001\u533b\u85ac\u54c1\u306e\u8abf\u9054\u3001\u88fd\u9020\u62e0\u70b9\u306e\u6c7a\u5b9a\u3001\u304a\u3088\u3073\u30a2\u30c0\u30d1\u30ec\u30f3\u88fd\u54c1\u306e\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u306e\u30ec\u30b8\u30ea\u30a8\u30f3\u30b9\u306b\u91cd\u5927\u306a\u5f71\u97ff\u3092\u4e0e\u3048\u307e\u3059\u3002\u95a2\u7a0e\u30b9\u30b1\u30b8\u30e5\u30fc\u30eb\u306e\u8abf\u6574\u3068\u8cbf\u6613\u5206\u985e\u306e\u898b\u76f4\u3057\u306f\u3001\u539f\u85ac\u3001\u8ce6\u5f62\u5264\u3001\u304a\u3088\u3073\u5b8c\u6210\u54c1\u306e\u7740\u5730\u30b3\u30b9\u30c8\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u3001\u8abf\u9054\u6c7a\u5b9a\u3068\u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u9078\u629e\u306b\u5f71\u97ff\u3092\u53ca\u307c\u3057\u307e\u3059\u3002\u7d44\u7e54\u306f\u3001\u6f5c\u5728\u7684\u306a\u6df7\u4e71\u3092\u8efd\u6e1b\u3059\u308b\u305f\u3081\u306b\u3001\u5951\u7d04\u6761\u4ef6\u3001\u30d8\u30c3\u30b8\u6226\u7565\u3001\u304a\u3088\u3073\u7dca\u6025\u5728\u5eab\u8a08\u753b\u3092\u8a55\u4fa1\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002\u95a2\u7a0e\u5909\u66f4\u306f\u3001\u30ed\u30fc\u30ab\u30e9\u30a4\u30bc\u30fc\u30b7\u30e7\u30f3\u306e\u8b70\u8ad6\u3092\u52a0\u901f\u3055\u305b\u3001\u88fd\u9020\u696d\u8005\u3084\u53d7\u8a17\u958b\u767a\u88fd\u9020\u6a5f\u95a2\uff08CDMO\uff09\u306b\u5bfe\u3057\u3001\u751f\u7523\u306e\u7d71\u5408\u5834\u6240\u3084\u5730\u57df\u7684\u306a\u4f9b\u7d66\u30bb\u30ad\u30e5\u30ea\u30c6\u30a3\u3092\u512a\u5148\u3059\u308b\u5e02\u5834\u3092\u518d\u8a55\u4fa1\u3059\u308b\u3088\u3046\u4fc3\u3059\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u8abf\u9054\u30c1\u30fc\u30e0\u306f\u3001\u69d8\u3005\u306a\u95a2\u7a0e\u5236\u5ea6\u3092\u8003\u616e\u3057\u305f\u30b7\u30ca\u30ea\u30aa\u30d7\u30e9\u30f3\u30cb\u30f3\u30b0\u3092\u884c\u3044\u3001\u7279\u6075\u8cbf\u6613\u5354\u5b9a\u3001\u95a2\u7a0e\u5206\u985e\u306e\u7570\u8b70\u7533\u3057\u7acb\u3066\u3001\u307e\u305f\u306f\u56fd\u5185\u80fd\u529b\u306e\u6d3b\u7528\u3092\u901a\u3058\u3066\u95a2\u7a0e\u8efd\u6e1b\u306e\u6a5f\u4f1a\u3092\u7279\u5b9a\u3059\u3079\u304d\u3067\u3059\u3002<\/p>\n<p>\u5730\u57df\u3054\u3068\u306e\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u3082\u5e02\u5834\u306b\u5927\u304d\u306a\u5f71\u97ff\u3092\u4e0e\u3048\u307e\u3059\u3002\u5730\u57df\u3054\u3068\u306e\u898f\u5236\u6163\u884c\u3001\u652f\u6255\u8005\u30b7\u30b9\u30c6\u30e0\u3001\u304a\u3088\u3073\u30c1\u30e3\u30cd\u30eb\u958b\u767a\u306b\u306f\u5927\u304d\u306a\u3070\u3089\u3064\u304d\u304c\u3042\u308a\u3001\u30a2\u30c0\u30d1\u30ec\u30f3\u88fd\u54c1\u306e\u30a2\u30af\u30bb\u30b9\u6226\u7565\u3068\u6226\u7565\u7684\u512a\u5148\u9806\u4f4d\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u307e\u3059\u3002\u7c73\u5dde\u3067\u306f\u3001\u4e2d\u592e\u96c6\u6a29\u7684\u306a\u898f\u5236\u8981\u4ef6\u3078\u306e\u5bfe\u5fdc\u3001\u51e6\u65b9\u85ac\u3068OTC\u30a2\u30af\u30bb\u30b9\u306e\u30d0\u30e9\u30f3\u30b9\u306e\u9032\u5316\u3001\u6210\u719f\u3057\u305f\u5c0f\u58f2\u85ac\u5c40\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u304c\u60a3\u8005\u3068\u306e\u63a5\u70b9\u3092\u5f62\u6210\u3057\u3066\u3044\u307e\u3059\u3002\u6b27\u5dde\u3001\u4e2d\u6771\u3001\u30a2\u30d5\u30ea\u30ab\uff08EMEA\uff09\u3067\u306f\u3001\u7570\u8cea\u306a\u898f\u5236\u74b0\u5883\u304c\u5b58\u5728\u3057\u3001\u5730\u57df\u56fa\u6709\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u8a08\u753b\u304c\u5fc5\u8981\u3068\u3055\u308c\u3001\u6d41\u901a\u7d4c\u8def\u3068\u51e6\u65b9\u96c6\u7ba1\u7406\u304c\u7ba1\u8f44\u533a\u57df\u9593\u3067\u5927\u304d\u304f\u7570\u306a\u308a\u307e\u3059\u3002\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u3067\u306f\u3001\u6025\u901f\u306a\u30c7\u30b8\u30bf\u30eb\u63a1\u7528\u3001\u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40\u306e\u6d78\u900f\u62e1\u5927\u3001\u898f\u5236\u306e\u53b3\u683c\u3055\u306e\u9055\u3044\u304c\u3001\u30e1\u30fc\u30ab\u30fc\u306b\u3068\u3063\u3066\u6a5f\u4f1a\u3068\u8907\u96d1\u3055\u306e\u4e21\u65b9\u3092\u751f\u307f\u51fa\u3057\u3066\u3044\u307e\u3059\u3002\u73fe\u5730\u88fd\u9020\u80fd\u529b\u3068\u591a\u69d8\u306a\u652f\u6255\u8005\u69cb\u9020\u3082\u3001\u767a\u58f2\u9806\u5e8f\u3068\u5546\u696d\u6295\u8cc7\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u5730\u57df\u9593\u306e\u5bfe\u7167\u306f\u3001\u7570\u306a\u308b\u30a2\u30af\u30bb\u30b9\u30e2\u30c7\u30eb\u3001\u60a3\u8005\u884c\u52d5\u3001\u304a\u3088\u3073\u4e16\u754c\u4e2d\u306e\u6a5f\u95a2\u8abf\u9054\u30d7\u30ed\u30bb\u30b9\u3092\u53cd\u6620\u3057\u305f\u3001\u5dee\u5225\u5316\u3055\u308c\u305f\u5e02\u5834\u53c2\u5165\u6226\u7565\u3001\u9069\u5fdc\u6027\u306e\u3042\u308b\u898f\u5236\u8a08\u753b\u3001\u304a\u3088\u3073\u67d4\u8edf\u306a\u30c1\u30e3\u30cd\u30eb\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306e\u5fc5\u8981\u6027\u3092\u5f37\u8abf\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30a2\u30c0\u30d1\u30ec\u30f3\u5e02\u5834\u306b\u304a\u3051\u308b\u7af6\u4e89\u529b\u5b66\u306f\u3001\u88fd\u5264\u9769\u65b0\u3001\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u306e\u4fe1\u983c\u6027\u3001\u304a\u3088\u3073\u5fcd\u5bb9\u6027\u3068\u6709\u52b9\u6027\u306b\u95a2\u3059\u308b\u81e8\u5e8a\u7684\u5dee\u5225\u5316\u306e\u80fd\u529b\u306b\u7126\u70b9\u3092\u5f53\u3066\u3066\u3044\u307e\u3059\u3002\u78ba\u7acb\u3055\u308c\u305f\u5148\u767a\u4f01\u696d\u306f\u3001\u30d6\u30e9\u30f3\u30c9\u8a8d\u77e5\u5ea6\u3068\u72ec\u81ea\u306e\u88fd\u5264\u5c02\u9580\u77e5\u8b58\u306b\u304a\u3044\u3066\u6226\u7565\u7684\u512a\u4f4d\u6027\u3092\u7dad\u6301\u3057\u3066\u304a\u308a\u3001\u7279\u306b\u5dee\u5225\u5316\u3055\u308c\u305f\u9001\u9054\u30b7\u30b9\u30c6\u30e0\u3084\u8aac\u5f97\u529b\u306e\u3042\u308b\u81e8\u5e8a\u30c7\u30fc\u30bf\u306b\u88cf\u6253\u3061\u3055\u308c\u3066\u3044\u308b\u5834\u5408\u306b\u9855\u8457\u3067\u3059\u3002\u5bfe\u7167\u7684\u306b\u3001\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u88fd\u5264\u306e\u30e1\u30fc\u30ab\u30fc\u306f\u3001\u30b3\u30b9\u30c8\u52b9\u7387\u3001\u88fd\u9020\u898f\u6a21\u3001\u304a\u3088\u3073\u30bf\u30fc\u30b2\u30c3\u30c8\u3092\u7d5e\u3063\u305f\u30c1\u30e3\u30cd\u30eb\u6d41\u901a\u3092\u6d3b\u7528\u3057\u3066\u3001\u4fa1\u683c\u306b\u654f\u611f\u306a\u30bb\u30b0\u30e1\u30f3\u30c8\u3067\u306e\u30a2\u30af\u30bb\u30b9\u3092\u78ba\u4fdd\u3057\u3066\u3044\u307e\u3059\u3002\u53d7\u8a17\u88fd\u9020\u696d\u8005\u3084\u5c02\u9580\u76ae\u819a\u79d1\u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u306f\u3001\u88fd\u54c1\u591a\u69d8\u5316\u3092\u53ef\u80fd\u306b\u3059\u308b\u4e0a\u3067\u91cd\u8981\u306a\u5f79\u5272\u3092\u679c\u305f\u3057\u3001\u4f01\u696d\u304c\u9650\u3089\u308c\u305f\u8a2d\u5099\u6295\u8cc7\u3067\u4ee3\u66ff\u88fd\u5264\u3084\u5f37\u5ea6\u3092\u8a66\u3059\u3053\u3068\u3092\u53ef\u80fd\u306b\u3057\u307e\u3059\u3002\u6226\u7565\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3001\u30e9\u30a4\u30bb\u30f3\u30b9\u5951\u7d04\u3001\u304a\u3088\u3073\u81e8\u5e8a\u7814\u7a76\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u3068\u306e\u5354\u529b\u306f\u3001\u30a8\u30d3\u30c7\u30f3\u30b9\u751f\u6210\u3092\u52a0\u901f\u3057\u3001\u8a8d\u8b58\u3055\u308c\u308b\u4fa1\u5024\u63d0\u6848\u3092\u62e1\u5927\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u3053\u306e\u5e02\u5834\u3067\u6210\u529f\u3092\u53ce\u3081\u308b\u4f01\u696d\u306f\u3001\u5805\u7262\u306a\u54c1\u8cea\u30b7\u30b9\u30c6\u30e0\u3001\u30a2\u30b8\u30e3\u30a4\u30eb\u306a\u88fd\u9020\u3001\u304a\u3088\u3073\u30ab\u30b9\u30bf\u30de\u30a4\u30ba\u3055\u308c\u305f\u5546\u696d\u30e2\u30c7\u30eb\u3092\u7d44\u307f\u5408\u308f\u305b\u3001\u51e6\u65b9\u533b\u306e\u597d\u307f\u3084\u30c1\u30e3\u30cd\u30eb\u306e\u6df7\u4e71\u306b\u5bfe\u5fdc\u3057\u306a\u304c\u3089\u3001\u88fd\u54c1\u306e\u5b8c\u5168\u6027\u3068\u60a3\u8005\u306e\u5b89\u5168\u6027\u3092\u4fdd\u8b77\u3059\u308b\u80fd\u529b\u304c\u6c42\u3081\u3089\u308c\u307e\u3059\u3002\u4e3b\u8981\u306a\u5e02\u5834\u30d7\u30ec\u30a4\u30e4\u30fc\u306b\u306f\u3001Galderma S.A.\u3001Sun Pharmaceutical Industries Ltd.\u3001Dr. Reddy&#8217;s Laboratories Ltd.\u3001Viatris Inc.\u3001Teva Pharmaceutical Industries Ltd.\u3001Glenmark Pharmaceuticals Limited\u3001Lupin Limited\u3001Cipla Limited\u3001Taro Pharmaceutical Industries Ltd.\u3001Sandoz International GmbH\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u3001\u5404\u793e\u304c\u5e02\u5834\u30b7\u30a7\u30a2\u3001\u6226\u7565\u7684\u30a4\u30cb\u30b7\u30a2\u30c1\u30d6\u3001\u304a\u3088\u3073\u7af6\u4e89\u4e0a\u306e\u30dd\u30b8\u30b7\u30e7\u30cb\u30f3\u30b0\u3092\u5de1\u3063\u3066\u7af6\u5408\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/posts\/52999"}],"collection":[{"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/comments?post=52999"}],"version-history":[{"count":2,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/posts\/52999\/revisions"}],"predecessor-version":[{"id":57010,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/posts\/52999\/revisions\/57010"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/media?parent=52999"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/categories?post=52999"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/tags?post=52999"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}